Matthew Seigerman

Matthew Seigerman practices at Surgery Center of Fairfield County in Trumbull, Connecticut.

Matthew Seigerman's NPI, 1164817623, was assigned on April 1, 2015. Matthew Seigerman graduated from Icahn School Of Medicine At Mount Sinai in 2015. Matthew Seigerman holds Connecticut license 70183.

Matthew Seigerman's primary practice is Surgery Center of Fairfield County, at 112 Quarry Road, Trumbull, CT 06611. The practice phone is (203) 374-1515.

Matthew Seigerman's primary practice is Surgery Center of Fairfield County in Trumbull, Connecticut. Matthew Seigerman is also affiliated with Yale New Haven Hospital. The medical group on file is Northeast Medical Group. Dmand AI also links Matthew Seigerman to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Seigerman practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Matthew Seigerman's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Matthew Seigerman is licensed in Connecticut.

CMS data shows 3,635 Medicare services from Matthew Seigerman across 22 procedure codes in 2024, for 1,700 Medicare patients. Medicare paid $169,756 for them.

CMS counts 1,700 Medicare patients who saw Matthew Seigerman in 2024. The largest group is 75 to 84, with 645 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Seigerman's median patient age at 75, with 51% women.

In 2024, Matthew Seigerman wrote 6,680 Medicare Part D claims for 793 patients. 84% of them were for generic drugs. CMS names the drug for 6,432 of them, across 56 drugs with 11 or more claims each, at $1,489,623 in total drug cost. In 2023, CMS named 2,817 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Matthew Seigerman for performance year 2024, reported through an alternative payment model (APM). Matthew Seigerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Seigerman as offering telehealth. CMS counts 27 procedures of coronary angioplasty and stenting by Matthew Seigerman, more than 61% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Matthew Seigerman, published from 2013 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Cardiovascular Diseases, COVID-19 and Heart-Assist Devices. Matthew Seigerman has published most often in Circ Cardiovasc Interv. Matthew Seigerman's most frequent co-authors are Daniel M. Kolansky, MD, Ashwin Senthil Nathan, MD and Michael A. Acker, MD.

CMS Open Payments shows 63 general payments to Matthew Seigerman from 9 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 62% of the total. Edwards Lifesciences Corporation paid the most, $1,469.

Matthew Seigerman graduated from Icahn School Of Medicine At Mount Sinai in 2015.